SATS vs. AZN
SATS (EchoStar Corporation) and AZN (AstraZeneca PLC) are both stocks. SATS operates in Communication Equipment (Technology), while AZN operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, SATS returned 82.88%/yr vs 15.97%/yr for AZN. At a 0.21 correlation, their price movements are largely independent.
Performance
SATS vs. AZN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SATS achieves a 4.95% return, which is significantly higher than AZN's -0.75% return. Over the past 10 years, SATS has outperformed AZN with an annualized return of 82.88%, while AZN has yielded a comparatively lower 15.97% annualized return.
SATS
- 1D
- -10.97%
- 1M
- -14.37%
- YTD
- 4.95%
- 6M
- 6.25%
- 1Y
- 531.15%
- 3Y*
- 87.23%
- 5Y*
- 33.39%
- 10Y*
- 82.88%
AZN
- 1D
- -1.94%
- 1M
- -4.78%
- YTD
- -0.75%
- 6M
- 1.57%
- 1Y
- 22.51%
- 3Y*
- 8.94%
- 5Y*
- 11.28%
- 10Y*
- 15.97%
SATS vs. AZN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SATS EchoStar Corporation | 4.95% | 374.67% | 38.20% | -0.66% | -36.70% | 24.35% | -51.07% | 16,499.32% | -38.70% | 16.56% |
AZN AstraZeneca PLC | -0.75% | 43.30% | -0.62% | 1.44% | 19.14% | 19.66% | 3.12% | 35.68% | 13.86% | 33.10% |
Correlation
The correlation between SATS and AZN is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2008 | 0.21 |
Fundamentals
SATS:
$32.97B
AZN:
$279.03B
SATS:
-$80.77
AZN:
$6.66
SATS:
2.22
AZN:
4.62
SATS:
5.85
AZN:
5.90
SATS:
$14.80B
AZN:
$60.44B
SATS:
$5.79B
AZN:
$49.37B
SATS:
-$16.89B
AZN:
$20.47B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SATS vs. AZN — Risk / Return Rank
SATS
AZN
SATS vs. AZN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for EchoStar Corporation (SATS) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SATS | AZN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +4.17 | ||
| Sortino ratioReturn per unit of downside risk | +4.56 | ||
| Omega ratioGain probability vs. loss probability | 1.80 | 1.17 | +0.63 |
| Calmar ratioReturn relative to maximum drawdown | 26.91 | 1.47 | +25.44 |
| Martin ratioReturn relative to average drawdown | 48.80 | 3.82 | +44.97 |
Loading charts...
Drawdowns
SATS vs. AZN - Drawdown Comparison
The maximum SATS drawdown since its inception was -78.33%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for SATS and AZN.
Loading charts...
Drawdown Indicators
| SATS | AZN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.33% | -48.94% | -29.39% |
Max Drawdown (1Y)Largest decline over 1 year | -19.91% | -15.43% | -4.48% |
Max Drawdown (3Y)Largest decline over 3 years | -59.22% | -27.87% | -31.35% |
Max Drawdown (5Y)Largest decline over 5 years | -68.02% | -27.87% | -40.15% |
Max Drawdown (10Y)Largest decline over 10 years | -78.33% | -27.87% | -50.46% |
Current DrawdownCurrent decline from peak | -19.55% | -14.25% | -5.30% |
Average DrawdownAverage peak-to-trough decline | -31.21% | -11.37% | -19.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.97% | 5.99% | +4.98% |
Volatility
SATS vs. AZN - Volatility Comparison
EchoStar Corporation (SATS) has a higher volatility of 22.65% compared to AstraZeneca PLC (AZN) at 7.95%. This indicates that SATS's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SATS | AZN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.65% | 7.95% | +14.70% |
Volatility (6M)Calculated over the trailing 6-month period | 41.93% | 17.74% | +24.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 106.03% | 25.76% | +80.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 69.48% | 24.03% | +45.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 4,550.46% | 24.93% | +4,525.53% |
Dividends
SATS vs. AZN - Dividend Comparison
SATS has not paid dividends to shareholders, while AZN's dividend yield for the trailing twelve months is around 2.98%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 2.98% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
SATS EchoStar Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 85.50% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
SATS vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between EchoStar Corporation and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SATS vs. AZN - Profitability Comparison
SATS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, EchoStar Corporation reported a gross profit of 1.67B and revenue of 3.67B. Therefore, the gross margin over that period was 45.5%.
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.
SATS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, EchoStar Corporation reported an operating income of 392.85M and revenue of 3.67B, resulting in an operating margin of 10.7%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.
SATS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, EchoStar Corporation reported a net income of -189.14M and revenue of 3.67B, resulting in a net margin of -5.2%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.
Frequently Asked Questions
SATS and AZN have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SATS has higher volatility (22.65%) compared to AZN (7.95%). In terms of maximum drawdown, SATS dropped -78.33% vs AZN's -48.94%.
SATS currently has the higher Sharpe Ratio (5.06 vs 0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SATS and AZN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer